KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables - Other (2016 - 2021)

Historic Receivables - Other for Quest Diagnostics (DGX) over the last 9 years, with Q1 2021 value amounting to $5.0 million.

  • Quest Diagnostics' Receivables - Other changed 0.0% to $5.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 million for FY2020, which is 2500.0% down from last year.
  • Latest data reveals that Quest Diagnostics reported Receivables - Other of $5.0 million as of Q1 2021, which was down 0.0% from $3.0 million recorded in Q4 2020.
  • In the past 5 years, Quest Diagnostics' Receivables - Other ranged from a high of $13.0 million in Q2 2017 and a low of $3.0 million during Q4 2017
  • Its 5-year average for Receivables - Other is $4.9 million, with a median of $4.0 million in 2018.
  • In the last 5 years, Quest Diagnostics' Receivables - Other surged by 8333.33% in 2017 and then plummeted by 7692.31% in 2018.
  • Quarter analysis of 5 years shows Quest Diagnostics' Receivables - Other stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then soared by 33.33% to $4.0 million in 2019, then decreased by 25.0% to $3.0 million in 2020, then skyrocketed by 66.67% to $5.0 million in 2021.
  • Its Receivables - Other stands at $5.0 million for Q1 2021, versus $3.0 million for Q4 2020 and $4.0 million for Q3 2020.